Group 1 - The event "Industrial and Information Lecture Hall" focused on the digital transformation of the biopharmaceutical industry, with over 100 participants including government officials and industry representatives [1][3] - The event included site visits to Hengxiutang Pharmaceutical Co., Ltd. and Sinocare Inc., where attendees learned about digital transformation experiences [3] - More than 100 small and medium-sized enterprises in Changsha's biopharmaceutical sector are participating in the third batch of transformation trials, creating multiple typical application scenarios and innovative dual-line integration models [3] Group 2 - Hengxiutang Pharmaceutical's digital transformation leader shared insights on the underlying logic and implementation paths of digital transformation, addressing pain points in traditional Chinese medicine manufacturing [3] - The next steps for the industrial system include building a "government-industry-university-research-application" platform to tackle common technologies like AI quality control and drug traceability [3] - The initiative aims to support benchmark enterprises in sharing transformation experiences and encourage personalized intelligent manufacturing scenarios, while also focusing on cultivating interdisciplinary talent through collaboration with universities and research institutions [3]